Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C477819 |
15-deoxyprostaglandin J2 |
15-deoxyprostaglandin J2 results in decreased localization of EP300 protein | decreases localization | 15641079
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of EP300 mRNA | affects expression | 21346803
|
C090942 |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in decreased expression of EP300 protein] | decreases expression|decreases reaction | 15767673
|
C090942 |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in increased degradation of EP300 protein] | decreases reaction|increases degradation | 15767673
|
C090942 |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [MAP2K6 protein results in decreased expression of EP300 protein] | decreases expression|decreases reaction | 15767673
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone promotes the reaction [AR protein binds to EP300 protein] | affects binding|increases reaction | 18487222
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone promotes the reaction [EP300 protein binds to KLK3 promoter] | affects binding|increases reaction | 18487222
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of EP300 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide promotes the reaction [EP300 protein binds to and results in increased acetylation of TP73 protein] | affects binding|increases acetylation|increases reaction | 15031205
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased activity of EP300 protein | increases activity | 15031205
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of EP300 mRNA | increases expression | 20458559
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Curcumin affects the localization of EP300 protein] | affects localization|decreases reaction | 17927689
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Curcumin results in decreased expression of EP300 mRNA] | decreases expression|decreases reaction | 17927689
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Curcumin results in decreased expression of EP300 protein] | decreases expression|decreases reaction | 17927689
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Doxorubicin results in increased degradation of EP300 protein] | decreases reaction|increases degradation | 15767673
|
D002166 |
Camptothecin |
Camptothecin results in decreased expression of EP300 mRNA | decreases expression | 10344722
|
D002166 |
Camptothecin |
Camptothecin results in decreased expression of EP300 protein | decreases expression | 10344722
|
D003474 |
Curcumin |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Curcumin affects the localization of EP300 protein] | affects localization|decreases reaction | 17927689
|
D003474 |
Curcumin |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Curcumin results in decreased expression of EP300 mRNA] | decreases expression|decreases reaction | 17927689
|
D003474 |
Curcumin |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Curcumin results in decreased expression of EP300 protein] | decreases expression|decreases reaction | 17927689
|
D003474 |
Curcumin |
Curcumin affects the localization of EP300 protein | affects localization | 17927689
|
D003474 |
Curcumin |
Curcumin results in decreased expression of EP300 mRNA | decreases expression | 17927689
|
D003474 |
Curcumin |
Curcumin results in decreased expression of EP300 protein | decreases expression | 17927689
|
C014347 |
decitabine |
decitabine affects the methylation of EP300 promoter | affects methylation | 17965222
|
C014347 |
decitabine |
decitabine promotes the reaction [EP300 protein binds to TP53 protein] | affects binding|increases reaction | 17977830
|
D003907 |
Dexamethasone |
EP300 protein promotes the reaction [Dexamethasone results in increased expression of UCP3 mRNA] | increases expression|increases reaction | 17884810
|
D003907 |
Dexamethasone |
SIRT1 protein inhibits the reaction [EP300 protein promotes the reaction [Dexamethasone results in increased expression of UCP3 mRNA]] | decreases reaction|increases expression|increases reaction | 17884810
|
D002945 |
Cisplatin |
Cisplatin results in decreased expression of EP300 protein | decreases expression | 17498666
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in decreased expression of EP300 protein | decreases expression | 15019724
|
D002117 |
Calcitriol |
Calcitriol affects the localization of EP300 protein | affects localization | 15647825
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [EP300 protein binds to CYP24A1 promoter] | affects binding|increases reaction | 15647825
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [EP300 protein binds to SPP1 promoter] | affects binding|increases reaction | 15647825
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of EP300 mRNA | decreases expression | 10344722
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of EP300 protein | decreases expression | 17498666 10344722
|
D004317 |
Doxorubicin |
[1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine co-treated with Doxorubicin] results in increased expression of EP300 protein | affects cotreatment|increases expression | 15767673
|
D004317 |
Doxorubicin |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in decreased expression of EP300 protein] | decreases expression|decreases reaction | 15767673
|
D004317 |
Doxorubicin |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in increased degradation of EP300 protein] | decreases reaction|increases degradation | 15767673
|
D004317 |
Doxorubicin |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Doxorubicin results in increased degradation of EP300 protein] | decreases reaction|increases degradation | 15767673
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of EP300 protein | decreases expression | 15767673
|
D004317 |
Doxorubicin |
Doxorubicin results in increased phosphorylation of and results in increased degradation of EP300 protein | increases degradation|increases phosphorylation | 15767673
|
D004317 |
Doxorubicin |
SB 203580 inhibits the reaction [Doxorubicin results in decreased expression of EP300 protein] | decreases expression|decreases reaction | 15767673
|
D004610 |
Ellagic Acid |
Ellagic Acid results in increased expression of EP300 mRNA | increases expression | 12002526
|
D004958 |
Estradiol |
Estradiol promotes the reaction [EP300 protein binds to BRCA1 promoter] | affects binding|increases reaction | 16489025
|
D004958 |
Estradiol |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol promotes the reaction [EP300 protein binds to BRCA1 promoter]] | affects binding|decreases reaction|increases reaction | 16489025
|
D004958 |
Estradiol |
Estradiol promotes the reaction [[EP300 protein binds to VEGFA promoter] which results in increased expression of VEGFA mRNA] | affects binding|increases expression|increases reaction | 15774498
|
D019307 |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine |
[1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine co-treated with Doxorubicin] results in increased expression of EP300 protein | affects cotreatment|increases expression | 15767673
|
D019307 |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine results in increased expression of EP300 protein | increases expression | 15767673
|
C051890 |
irinotecan |
irinotecan metabolite results in decreased expression of EP300 mRNA | decreases expression | 15956246
|
C051890 |
irinotecan |
irinotecan results in decreased expression of EP300 mRNA | decreases expression | 15956246
|
C011890 |
kojic acid |
kojic acid results in increased expression of EP300 mRNA | increases expression | 16595896
|
D009151 |
Mustard Gas |
Mustard Gas results in decreased expression of EP300 mRNA | decreases expression | 18955075
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein]] | affects binding|decreases reaction|increases reaction | 16928824
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [Phenylephrine results in increased expression of EP300 mRNA] | decreases reaction|increases expression | 11705990
|
D010656 |
Phenylephrine |
EP300 protein promotes the reaction [[Phenylephrine results in increased activity of GATA4 protein] which results in increased expression of EDN1 mRNA] | increases activity|increases expression|increases reaction | 12724418
|
D010656 |
Phenylephrine |
EP300 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 11705990
|
D010656 |
Phenylephrine |
EP300 protein promotes the reaction [Phenylephrine results in increased expression of MYH7 mRNA] | increases expression|increases reaction | 15593114
|
D010656 |
Phenylephrine |
EP300 protein results in increased susceptibility to Phenylephrine | increases response to substance | 12477714
|
D010656 |
Phenylephrine |
MAPK1 protein promotes the reaction [Phenylephrine results in increased expression of EP300 mRNA] | increases expression|increases reaction | 11705990
|
D010656 |
Phenylephrine |
PD 98059 inhibits the reaction [Phenylephrine results in increased expression of EP300 mRNA] | decreases reaction|increases expression | 11705990
|
D010656 |
Phenylephrine |
Phenylephrine promotes the reaction [GATA4 protein binds to EP300 protein] | affects binding|increases reaction | 15220332
|
D010656 |
Phenylephrine |
[Phenylephrine results in increased activity of EP300 protein] which results in increased expression of NPPA protein | increases activity|increases expression | 12477714
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of EP300 mRNA | increases expression | 11705990
|
D010656 |
Phenylephrine |
Phenylephrine results in increased phosphorylation of and results in increased activity of EP300 protein | increases activity|increases phosphorylation | 15006641
|
D010656 |
Phenylephrine |
ZFPM2 protein inhibits the reaction [Phenylephrine promotes the reaction [GATA4 protein binds to EP300 protein]] | affects binding|decreases reaction|increases reaction | 15220332
|
C059514 |
resveratrol |
PD 98059 inhibits the reaction [resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein]] | affects binding|decreases reaction|increases reaction | 16928824
|
C059514 |
resveratrol |
resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein] | affects binding|increases reaction | 16928824
|
C059514 |
resveratrol |
resveratrol results in increased expression of EP300 mRNA | increases expression | 12569576 12002526
|
C014794 |
retinol palmitate |
retinol palmitate promotes the reaction [EP300 protein binds to MMP9 protein] | affects binding|increases reaction | 17164434
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [Doxorubicin results in decreased expression of EP300 protein] | decreases expression|decreases reaction | 15767673
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [MAP2K6 protein results in decreased expression of EP300 protein] | decreases expression|decreases reaction | 15767673
|
C017947 |
sodium arsenite |
sodium arsenite inhibits the reaction [EP300 protein binds to IVL promoter] | affects binding|decreases reaction | 20006635
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of EP300 mRNA | decreases expression | 10344722
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of EP300 protein | decreases expression | 10344722
|
D013749 |
Tetrachlorodibenzodioxin |
EP300 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] | affects reaction|increases expression | 18842620
|
D013749 |
Tetrachlorodibenzodioxin |
EP300 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] | affects reaction|increases expression | 18842620
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [Estradiol promotes the reaction [EP300 protein binds to BRCA1 promoter]] | affects binding|decreases reaction|increases reaction | 16489025
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [EP300 protein binds to CYP1A1 enhancer] | affects binding|increases reaction | 18842620
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [EP300 protein binds to CYP1A1 promoter] | affects binding|increases reaction | 18842620
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [EP300 protein binds to CYP1B1 enhancer] | affects binding|increases reaction | 18842620
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [EP300 protein binds to CYP1B1 promoter] | affects binding|increases reaction | 18842620
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [EP300 protein binds to PTGS2 promoter] | affects binding|increases reaction | 19056653
|
D014212 |
Tretinoin |
EP300 protein promotes the reaction [Tretinoin results in increased expression of ITGB2 mRNA] | increases expression|increases reaction | 16581781
|
D014212 |
Tretinoin |
[GABPA protein binds to EP300 protein] promotes the reaction [Tretinoin results in increased expression of ITGB2 mRNA] | affects binding|increases expression|increases reaction | 16581781
|
D014212 |
Tretinoin |
Tretinoin inhibits the reaction [EP300 protein binds to RETN promoter] | affects binding|decreases reaction | 15047602
|
C012589 |
trichostatin A |
trichostatin A affects the localization of EP300 protein | affects localization | 15647279
|
C012589 |
trichostatin A |
trichostatin A promotes the reaction [EP300 protein binds to TGFBR2 promoter] | affects binding|increases reaction | 15647279
|
C012589 |
trichostatin A |
trichostatin A promotes the reaction [[EP300 protein co-treated with EGR1 protein] results in increased expression of PTEN mRNA] | affects cotreatment|increases expression|increases reaction | 17330857
|
C012589 |
trichostatin A |
EP300 protein results in increased susceptibility to trichostatin A | increases response to substance | 12477714
|
D015032 |
Zinc |
Zinc affects the expression of EP300 protein | affects expression | 16636310
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.54 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.25 | 18287403 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.09 | 16889938 17190629 17202136 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
7.97 | 15814532 12690470 17670903 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
7.97 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.52 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
9.52 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.52 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.52 | 11473722 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.14 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.07 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.38 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.59 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.25 | 21441931 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.77 | 17887948 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.37 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
6.32 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
6.32 | 16162502 16183991 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
6.32 | 16410023 17119284 16580781 16325427 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.18 | 15469931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.68 | 11748828 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.61 | 16916123 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.85 | 17460149 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
11.28 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
11.28 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
11.28 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
4.47 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.47 | 16292516 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
7.41 | 10378619 |
MESH:D001249 |
Asthma |
|
Tretinoin |
7.41 | 16456186 |
MESH:D001249 |
Asthma |
|
Zinc |
7.41 | 17085522 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
6.30 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.30 | 16873680 17967414 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
4.19 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.11 | 16935849 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.85 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
13.73 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.73 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
13.73 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.47 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.57 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
11.00 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
11.00 | 14601052 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.23 | 15306635 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.39 | 17109824 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
9.29 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
9.29 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
8.07 | 17596214 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
8.07 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
6.65 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
6.65 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
6.65 | 19250217 18462866 18593918 16243823 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
6.65 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
6.65 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
6.65 | 15136595 16935488 16096432 15994142 18628466 18382427 16264153 15993339 18695136 16322301 15939500 15634643 19526202 18234424 16826403 15567936 17369602 16595493 11325840 15668708 17426702 16115903 17983394 15692762 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
6.65 | 17289903 12948864 17261762 18497071 19861407 17018787 14630087 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
6.65 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.65 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
6.65 | 16166294 16873071 16443354 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.85 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.66 | 17687719 10378619 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.28 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.04 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.15 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.49 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
7.48 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.48 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.84 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
18.81 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
18.81 | 15553829 14691202 11135700 16217749 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
18.81 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
18.81 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
18.81 | 16234567 18059187 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
18.81 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
18.81 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
18.81 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
18.81 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.28 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
5.41 | 16685392 12023789 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
5.41 | 18414057 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.56 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.01 | 16201981 1485588 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.85 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
marker/mechanism |
|
| 17965222 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
32.53 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
32.53 | 6189445 17066447 18337622 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
32.53 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
32.53 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
32.53 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
32.53 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
retinol palmitate |
32.53 | 15984520 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
32.53 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
32.53 | 16096774 16051514 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
32.53 | 16543248 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.31 | 15728586 11754973 17124262 11179087 16170337 17287366 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.31 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.33 | 16952015 16364871 16278810 17519947 17007740 17131338 15792986 16651473 17928571 17308081 16612575 16731534 17974986 17329180 17924179 15476868 16455267 16269455 16242529 16109756 15505089 15811867 17351982 17382496 18627295 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.84 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.94 | 15458977 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
6.94 | 16936243 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.91 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.04 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.04 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.28 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.90 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.84 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.45 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.32 | 15668235 8697196 16354765 15340226 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.32 | 9407595 |
MESH:D003092 |
Colitis |
|
Curcumin |
14.34 | 16782535 16804969 18200517 |
MESH:D003092 |
Colitis |
|
resveratrol |
14.34 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
14.34 | 17035595 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.27 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
10.43 | 16340194 19359593 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
10.43 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
10.43 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
10.43 | 17287894 17725105 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
10.43 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
7.96 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
7.96 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
7.96 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
7.96 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
7.96 | 18259882 15273666 16391804 16303861 17159606 17454858 18509181 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
7.96 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.80 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.59 | 18497527 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.55 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.89 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
6.93 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
6.93 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.93 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
6.93 | 9142499 17551590 9211117 10589399 9125849 16925845 8800419 9664655 9224671 14991402 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
6.93 | 19302082 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.26 | 12952375 16002989 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.71 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.81 | 15213294 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.12 | 12438553 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
8.53 | 16285004 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
8.53 | 16479319 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.52 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
4.13 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.13 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
13.60 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.60 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
13.60 | 16286809 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.41 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.18 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
8.18 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
8.18 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.18 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
12.46 | 19839026 12231392 15033597 12649298 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
12.46 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
12.46 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.76 | 17351913 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.16 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
14.23 | 19703484 |
MESH:D004487 |
Edema |
|
Mustard Gas |
14.23 | 11428631 11428647 9260866 11402378 |
MESH:D004487 |
Edema |
|
resveratrol |
14.23 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
14.23 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.89 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.89 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
8.42 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
8.42 | 17872969 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
12.97 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
12.97 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
4.38 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
16.14 | 16804899 15700306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
16.14 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
16.14 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
16.14 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.76 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.84 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.54 | 17923197 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.85 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
marker/mechanism |
|
| 17965222 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
6.91 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
6.91 | 16481741 17638652 15464296 16785472 15173087 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
6.91 | 16543248 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.08 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.08 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
7.15 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
7.15 | 19297423 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.47 | 16611131 16513791 16534752 16002989 15751030 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.15 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.28 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
13.07 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.07 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
13.07 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.97 | 16904648 |
MESH:D005756 |
Gastritis |
|
Zinc |
4.48 | 17241300 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.39 | 18462866 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
11.78 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
11.78 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
15.35 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
15.35 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
15.35 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
15.35 | 18801729 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.28 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.76 | 17217573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
27.45 | 15102660 15464296 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
27.45 | 18462866 18829502 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
27.45 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
27.45 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
retinol palmitate |
27.45 | 15984520 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
27.45 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.04 | 19898482 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.84 | 16084493 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.17 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.99 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.99 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.27 | 14766674 16244371 16879835 16707910 16330681 16144979 17875725 12587719 16244372 17888722 18006777 18674790 16495754 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.81 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Zinc |
6.81 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.45 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.25 | 17241300 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.63 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.06 | 11000095 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.39 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.59 | 16120746 15340226 12621046 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.74 | 17701891 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.96 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.72 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.87 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
10.85 | 16170182 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
10.85 | 15147373 18501091 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
10.85 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.44 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.73 | 15340226 16959395 8697196 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
2.97 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
8.46 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
8.46 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.26 | 16778211 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.74 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.13 | 14722030 12960047 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
8.01 | 17042910 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
8.01 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.01 | 18670907 18850075 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.28 | 18502941 12791704 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.03 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.28 | 16002989 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.34 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.06 | 15036965 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
6.22 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.22 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Curcumin |
14.14 | 17151092 18403477 16956363 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
14.14 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
14.14 | 17524151 8975870 11428620 9357497 9260866 11428631 11428647 16001271 11402378 |
MESH:D007249 |
Inflammation |
|
resveratrol |
14.14 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
14.14 | 12200463 12878042 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
3.08 | 18596194 18200517 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.23 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.76 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
6.76 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.46 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.95 | 10783313 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.33 | 16584753 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.01 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.01 | 15992940 17551590 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.82 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
17.17 | 15190930 12649298 19839026 18289764 12231392 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
17.17 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
17.17 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
17.17 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
17.17 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
9.26 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
9.26 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
11.02 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
11.02 | 15003126 14681315 16762066 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.02 | 15610895 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.48 | 11231351 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.76 | 17184923 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
4.28 | 18555241 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
13.69 | 15070760 |
MESH:D007938 |
Leukemia |
|
Curcumin |
13.69 | 18462866 |
MESH:D007938 |
Leukemia |
|
decitabine |
13.69 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
13.69 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.84 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
8.84 | 12560223 17077332 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
8.84 | 16106398 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
10.69 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
10.69 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.20 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
14.39 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
14.39 | 19117987 17236224 18454857 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
14.39 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
8.27 | 16467208 17050201 16968895 19850784 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
8.27 | 18704418 19010910 19387464 18460780 18206229 17679729 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
8.27 | 16294345 17596541 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
8.27 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.15 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
11.61 | 12712474 19075265 19035177 12679006 17649720 11161223 16891316 17869043 16823087 15622746 11468182 15748426 19642359 16331271 16112521 17217047 17712046 16966277 15213294 12018890 9834237 19225113 17107899 16330433 15336539 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
11.61 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
11.61 | 16823087 17368321 17712046 17217047 17107899 16331271 19075265 16140955 17361223 12679006 19035177 16935935 9834237 17301526 19642359 17506722 16766008 16891316 16788101 19029980 17339181 19225113 17294898 17649720 15748426 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
10.73 | 16882451 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
10.73 | 16106398 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.09 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
8.18 | 18705752 18006644 17355460 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
8.18 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
8.18 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.18 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.18 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
8.18 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
2.54 | 16956363 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
12.94 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
12.94 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
12.94 | 19812893 19321006 19073162 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
12.94 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
12.94 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
12.57 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
12.57 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
12.57 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.57 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.12 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
6.85 | 18702808 18161513 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.85 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
12.24 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
12.24 | 6189445 17225452 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
12.24 | 16243823 18462866 19359593 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
12.24 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
12.24 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
12.24 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
12.24 | 19931552 16712894 15276417 17306315 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
12.24 | 11884234 19555203 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.84 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
16.11 | 18462866 |
MESH:D008223 |
Lymphoma |
|
decitabine |
16.11 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
16.11 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
16.11 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
9.32 | 17088997 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
9.32 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
8.05 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
8.05 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
10.55 | 16173963 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
10.55 | 15621674 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.20 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.94 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
12.69 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
12.69 | 11807958 16891317 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
12.69 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
12.69 | 12773700 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.17 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.66 | 17453147 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
17.39 | 12883367 16809738 18332650 12374674 18176117 18505091 11135225 16432458 15577323 17761969 12393984 17023156 16248763 |
MESH:D008545 |
Melanoma |
|
Curcumin |
17.39 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
decitabine |
17.39 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
17.39 | 16827129 |
MESH:D008545 |
Melanoma |
|
resveratrol |
17.39 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
17.39 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
17.39 | 16752155 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
17.39 | 16505122 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.46 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.86 | 17263510 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.12 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
6.03 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.03 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.10 | 17112576 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.22 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
11.38 | 17415656 |
MESH:D052016 |
Mucositis |
|
irinotecan |
11.38 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
25.41 | 19417148 14977855 11468182 19549372 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
25.41 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
25.41 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
25.41 | 15867202 16118317 15744524 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
25.41 | 17935668 16490592 14749477 17049120 16267019 17164350 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
25.41 | 18172295 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
11.38 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
11.38 | 17962980 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.36 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
16.13 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
16.13 | 18608210 19157545 19010910 16882708 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
16.13 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
16.13 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.59 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.59 | 16525036 16456233 17188708 17125593 16317513 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.20 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.20 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.05 | 16810080 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.45 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.55 | 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
9.34 | 16624393 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
9.34 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.68 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
5.68 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
14.08 | 16773208 |
MESH:D009369 |
Neoplasms |
|
decitabine |
14.08 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
14.08 | 15313581 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
14.08 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
14.08 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.22 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.22 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
4.22 | 12497104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.42 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.18 | 15464296 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.46 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.74 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
21.01 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
21.01 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
21.01 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
21.01 | 9125849 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.31 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
10.98 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
10.98 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
10.98 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
10.59 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
10.59 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
10.59 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.56 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
10.43 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
10.43 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.11 | 17929310 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.69 | 7688884 16761898 |
MESH:D009765 |
Obesity |
|
Curcumin |
2.67 | 19297423 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.16 | 16049721 12819281 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
3.28 | 18719352 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.97 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.87 | 15930896 |
MESH:D010033 |
Otitis Media |
|
retinol palmitate |
6.56 | 17303254 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
25.34 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
25.34 | 19769630 17225452 6897625 15464296 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
25.34 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
25.34 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
25.34 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
25.34 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
25.34 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
25.34 | 19331143 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.66 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
19.00 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
19.00 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
19.00 | 17440100 19401701 19196508 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
19.00 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
19.00 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
19.00 | 19294695 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.88 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.93 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.01 | 15464296 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.84 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.85 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.37 | 16977796 15687265 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
12.88 | 17638057 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
12.88 | 17638057 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.51 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.26 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.37 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.94 | 17114810 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
14.51 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
14.51 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
14.51 | 11222880 11399792 11118676 11896295 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
11.41 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
11.41 | 17616702 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.47 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.61 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
4.08 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
4.08 | 12479363 16289102 18247401 15754350 16644109 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
4.08 | 18769126 12497104 18226269 18156803 10851300 15129424 11398177 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
4.08 | 15846301 15046698 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
4.08 | 15897917 15749863 18437689 16868541 16729912 16888761 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
4.08 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
4.08 | 17718901 17804756 15767336 17675339 16731767 17636462 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
4.08 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
4.08 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
4.08 | 19789329 18798265 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
4.08 | 12429649 16700911 16517595 16606632 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.32 | 16636307 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
3.78 | 18058305 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.48 | 16723453 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.26 | 19168576 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
2.81 | 17894541 17620002 17266442 17720292 10334151 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
9.37 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
9.37 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.27 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.12 | 16317513 16314181 17058453 17520802 15827377 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
8.36 | 10666014 18379247 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
8.36 | 18379247 11700416 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
3.90 | 16584753 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
9.99 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.99 | 16116481 16283617 |
MESH:D012415 |
Rubinstein-Taybi Syndrome |
marker/mechanism |
|
| |
MESH:D012509 |
Sarcoma |
|
Curcumin |
8.68 | 18462866 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
8.68 | 16767912 17203757 15625365 18313854 17710206 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
15.57 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
15.57 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
15.57 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.48 | 17846226 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.33 | 18551238 |
MESH:D018805 |
Sepsis |
|
Curcumin |
3.82 | 18389075 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.39 | 7327846 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.63 | 12880345 16961503 15451306 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
16.35 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
16.35 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
16.35 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
16.35 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
16.35 | 16467112 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.03 | 15464296 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.26 | 16767912 17203757 15625365 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
4.40 | 16709447 16002989 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.56 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.01 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
6.04 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
6.04 | 15958060 17522103 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
6.04 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
6.04 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
6.04 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
6.63 | 19188055 16631530 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
6.63 | 15138204 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.21 | 16321402 |
MESH:D024801 |
Tauopathies |
|
Camptothecin |
5.31 | 16930453 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.34 | 15464296 17225452 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.59 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
15.22 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
15.22 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
15.22 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
15.22 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.37 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
15.08 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
15.08 | 16051514 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
15.08 | 16543248 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.65 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.04 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
26.33 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
26.33 | 12845720 11780464 20435036 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
26.33 | 15464296 12973940 17225452 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
26.33 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
26.33 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
26.33 | 17306315 16712894 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
26.33 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
26.33 | 17306315 11723127 16712894 16452187 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.95 | 18462866 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.00 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
26.79 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
26.79 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
26.79 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
26.79 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
26.79 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.85 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
8.80 | 16690809 15809267 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
8.80 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
11.77 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
11.77 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.50 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
10.07 | 15577323 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
10.07 | 16002989 16513791 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.11 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.28 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
9.33 | 17334414 16364871 17678736 17638931 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
9.33 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.76 | 16761959 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.40 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.93 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.71 | 16287080 |